Christopher D. Maggiore - 14 Sep 2022 Form 4/A - Amendment Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
14 Sep 2022
Net transactions value
+$25,448
Form type
4/A - Amendment
Filing time
14 Feb 2023, 07:33:15 UTC
Date Of Original Report
19 Sep 2022
Previous filing
01 Aug 2022
Next filing
20 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIVO Common Stock Purchase $18,346 +5,200 +0.73% $3.53 721,282 14 Sep 2022 Direct F1, F3
transaction ZIVO Common Stock Purchase $7,101 +2,000 +0.28% $3.55 723,282 14 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.45 to $3.7257 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.435 to $3.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The total number of shares reported in Column 5 differs from amounts previously reported, which incorrectly included shares held in the estate of Robert S. McLain and in a related trust, as to which the reporting person was appointed a co-trustee in 2014. Although the reporting person has shared power to vote or to direct the vote, and shared power to dispose or to direct the disposition of, the shares held in the estate and in the trust, the reporting person has no direct or indirect pecuniary interest in such shares.